Prescribing menopausal hormone therapy (MHT) in women with cardiovascular risk factors—or a coronary artery calcium (CAC) score above zero—can raise clinical uncertainty. In this session, Dr. Nieca Goldberg will explore how to approach MHT in the context of evolving cardiovascular risk assessment tools. She’ll walk through the latest evidence, safety considerations, and patient selection strategies to help clinicians make nuanced, individualized decisions for women navigating menopause with elevated risk profiles.

Nieca Goldberg, MD, is a nationally recognized cardiologist, women’s health advocate, and Clinical Associate Professor of Medicine at NYU Grossman School of Medicine. She serves as Medical Director of Atria New York City and is the founder of the NYU Women’s Heart Program. A trailblazer in the field of women’s cardiovascular health, Dr. Goldberg has been a leading voice in raising awareness of heart disease in women, promoting sex-specific research, and advancing preventive care. She is also a best-selling author and frequent media contributor, committed to empowering women to take charge of their heart health.